AI-based Clinical Trials Solution Providers Market Players:
- Unlearn.AI, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Saama Technologies, LLC.
- Antidote Technologies, Inc.
- Biosymetrics
- Pharmaceutical Pipeline Enhancement Strategies, LLC
- Deep 6 AI Inc.
- Innoplexus AG
- Mendel.ai
- Intelligencia
- Median Technologies
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of AI-based clinical trials solution providers is evaluated at USD 3.26 billion.
The market size for the AI-based clinical trials solution providers is projected to reach USD 22.85 billion by the end of 2036, expanding at a CAGR of 21.5% during the forecast period i.e., between 2027-2036.
North America AI-based clinical trials solution providers market will hold around 43% share by 2036, driven by increasing AI tool penetration and government support in healthcare projects.
Key players in the market include Unlearn.AI, Inc., Saama Technologies, LLC., Antidote Technologies, Inc., Biosymetrics, Pharmaceutical Pipeline Enhancement Strategies, LLC, Deep 6 AI Inc., Innoplexus AG, Mendel.ai, Intelligencia, Median Technologies.
